Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

65 results about "Gynecological cancer" patented technology

Gynecologic cancer is a group of cancers that affect the tissue and organs of the female reproductive system. Each type of cancer is named after the organ it originates. Types of gynecologic cancer include: cervical cancer. ovarian cancer. uterine cancer. vaginal cancer. vulvar cancer.

Photosensitizers and MRI enhancers

The present invention relates to the use of a compound of formula 3 or a salt thereof for preparing a medicament or a phototherapeutic agent for the treatment of the following diseases, including: acne; AIDS; viral hepatitis; diabetic retinopathy; atypical pneumonia virus infection; coronary Arterial stenosis; carotid artery stenosis; intermittent claudication; Asian (chicken) avian influenza virus infection; cervical dysplasia or various cancers including: blood cancer, cervical cancer, nasopharyngeal cancer, tracheal cancer, laryngeal cancer, bronchial cancer , bronchiolar cancer, bladder cancer, esophagus cancer, stomach cancer, rectal cancer, colon cancer, prostate cancer, hollow organ cancer, bile duct cancer, urinary duct cancer, kidney cancer, uterine cancer, vaginal cancer and other gynecological adnexal cancers. The present invention also relates to methods of treating the above diseases. The present invention further relates to the use of a compound of formula 3 or a salt thereof for the preparation of a photodiagnostic agent for the detection of the above-mentioned diseases and diseases including: atherosclerosis, multiple sclerosis, diabetes, arthritis, rheumatism Arthritis, fungal infection, viral infection, chlamydia infection, bacterial infection, or parasitic infection, HIV infection, hepatitis, herpes simplex, shingles, psoriasis, cardiovascular disease and skin disease. The present invention also relates to methods of detecting the above diseases using photodiagnostic agents. The present invention further relates to a method of cryogenically sterilizing a surgical device or other device, comprising the steps of: providing a compound of formula 3 or a salt thereof on the device; subjecting the device to radiation treatment or sonication. The present invention further relates to a compound of formula 3 or a salt thereof linked or attached to a magnetic element. This compound acts as an MRI enhancer. The present invention also relates to the use of such MRI enhancers for performing MRI scans.
Owner:PHOTO DIAGNOSTIC DEVICES PDD

Compound nanoscale drug delivery system and application thereof in gynecological tumor treatment

The invention discloses a compound nanoscale drug delivery system and application thereof in gynecological tumor treatment. The compound nanoscale drug delivery system comprises (a) a paclitaxel and curcumin composition serving as an active component, (b) miRNA-HA serving as a targeted material, and (c) carboxylated magnetic mesoporous silica serving as a carrier. According to the compound nanoscale drug delivery system, the carboxylated magnetic mesoporous silica serves as the drug carrier, on one hand, a high drug encapsulation capacity is ensured, and on the other hand, modifiable sites areprovided for modification of functional groups; and through modification of the targeted material miRNA-HA, the tumor cell targeting capability and gynecological tumor cell targeted inhibition of thecarboxylated magnetic mesoporous silica nanoscale drug delivery system can be improved, and the inhibition rate of tumor cell migration and invasion is increased. The compound nanoscale drug deliverysystem is reasonable in method design and simple in preparation technology and thus has wide application prospects, and a foundation is also laid for design and development of corresponding drug delivery systems.
Owner:湖北绿无界生物科技有限公司

Myrrh target area for treatment of gynecological tumor and preparation method and application thereof

The invention discloses a myrrh target area for treatment of gynecological tumors and a preparation method and application thereof. The preparation method comprises the following steps: extracting with alcohol for myrrh and other solvents through supercritical fluid extraction, impregnation or reflux extraction to obtain alcohol extract; concentrating, suspending the concentrate with water, extracting with ether, petroleum ether, n-hexane or other low-polar solvents to obtain low-polar solvents extract; and concentrating, thereby obtaining the myrrh target area with 0-5 weight percent of diterpene and 0-30 weight percent of diterpenoid resin acid components. The invention combines the modern extraction and separation and the pharmacological activity screening to determine the optimal target area, the active ingredients of the prepared target area are clearer, the contents of the active ingredients are high and the results of in vitro anti-tumor experiments show that the myrrh target area provided by the invention has the function of inhibiting and killing multiple kinds of gynecological tumors with low dosage, and is expected to be developed as the novel traditional Chinese medicine with significant treatment effect and fewer low adverse reactions.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Aidi temperature/pH-sensitive in-situ gel preparation and preparation method thereof

The invention belongs to the field of traditional Chinese medicine preparations and relates to an Aidi temperature/pH-sensitive in-situ gel preparation and a preparation method thereof. The Aidi temperature/pH-sensitive in-situ gel preparation is prepared from Aidi extract, in-situ gel matrix acknowledged in the field and other pharmaceutically necessary auxiliary materials by the preparation method. The Aidi temperature/pH-sensitive in-situ gel preparation is liquid which can flow freely at a room temperature. After being taken by a patient, because of a temperature/pH change, the Aidi temperature/pH-sensitive in-situ gel preparation forms semisolid gel. The Aidi temperature/pH-sensitive in-situ gel preparation has the advantages of clear curative effects, stable properties, simple preparation, convenient administration method, strong compliance of patients, no toxic and side effects, no adverse effects and high bioavailability. The Aidi temperature/pH-sensitive in-situ gel preparation has functions of clearing heat, removing toxins, removing stasis and eliminating stagnation, and is suitable for treating a primary liver cancer, a lung cancer, a rectal cancer, a lymph cancer and gynecological cancers.
Owner:INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI

Gynecological tumor sample tissue sampling device

The invention belongs to the technical field of medical equipment, and particularly relates to a gynecological tumor sample tissue sampling device which comprises a protective cylinder, an injection cylinder, an injection needle and a sliding rod, and a closing cover capable of being opened and closed is arranged at one end of the protective cylinder; the syringe is arranged in the protective cylinder, the injection needle is connected to the end, close to the sealing cover, of the syringe, and the sliding rod is arranged in the syringe and abuts against the interior of the syringe; a first movable handle which simultaneously penetrates through the side wall of the injection cylinder and the side wall of the protective cylinder and is movable is connected to the sliding rod, and a second movable handle which penetrates through the side wall of the protective cylinder and is movable is connected to the side wall of the injection cylinder; and a limiting device and a fixed handle are arranged on the side wall of the protective cylinder. According to the device, the gun holding posture is kept in the sampling process, the hand easily exerts force, the device is easily held, the injection needle after sampling is located in the sealing cover, the sealing performance is good, and pollution is not likely to be caused.
Owner:HENAN CANCER HOSPITAL

Plaster for treating tumor and preparation method of plaster

The invention discloses a plaster for treating tumor. The plaster comprises the following components in parts by mass: angelica sinensis, donkey-hide gelatin, ginseng, atractylodes macrocephala, ligusticum wallichii, red-rooted salvia root, chicken's gizzard-membrane, full beach wormwood, turtle shells, spina gleditsiae, leech, scorpio, asarum sieboldi, garden balsam stem, borneol and alums. The invention further discloses a preparation method of the plaster for treating tumor. The plaster can be used for treating diseases such as benign tumor and hyperplasia such as thorax and abdomen tumor, including lung cancer, stomach cancer, liver cancer, esophagus cancer, pancreatic cancer, colorectal cancer, breast cancer, bone cancer, gynecological oncology (ovarian cancer and cervical cancer), urogenital neoplasms tumor (prostate cancer and carcinoma of urinary bladder) as well as hyperplasia of mammary glands, benign prostatic hyperplasia, mammary gland fibroma, uterine fibroids and the like, has the amazing effects of promoting the circulation of qi and dispersing blood stasis, resolving hard lump, supporting the healthy energy, removing swelling and relieving pain. The plaster can eliminate or relieve the symptom of patients, improve the immunity and the living quality, can eliminate tumor or keep people alive with the tumor, and can prolong the lives of the patients.
Owner:ANQIU JINKAIJIA PHARMA RES & DEV

Methods for diagnosis and/or prognosis of gynecological cancer

Ovarian, cervical cancer, endometriosis, clear cell renal carcinoma cancers are very heterogeneous diseases which lack robust diagnostic, prognostic and predictive clinical biomarkers. Conventional clinical biomarkers (stages, grades, tumor mass etc) and molecular biomarkers (CA125, KRAS, p53 etc) are not appropriate for early diagnostics, differential diagnostics, prediction and prognosis of the disease outcome for individual patients. The most common type of the human ovarian cancers is human epithelial ovarian cancer (EOC). This cancer is characterized with one of the lowest survival rates compared to other cancers. The present invention relates to an in vitro method for diagnosing epithelial ovarian cancer, cervical cancer, endometriosis, dear cell renal carcinoma and/or predisposition to epithelial ovarian cancer in a subject, the method comprising determining in a sample of the subject gene expression level of at least one gene in the MDS1 and EVI1 complex (MECOM) locus; and/or copy number of at least one gene in the MECOM locus; wherein the level against at least one expression cutoff value and/or copy number against at least one copy number cutoff value are indicative of the subject having epithelial ovarian cancer, cervical cancer, endometriosis, clear cell renal carcinoma and/or a predisposition to epithelial ovarian cancer, cervical cancer, endometriosis, dear cell renal carcinoma and/or determining whether the ovarian cancer in the subject is primary or secondary ovarian cancer and/or a risk of the disease progression after surgery treatment, and/or an effectiveness of post-surgery chemotherapy.
Owner:AGENCY FOR SCI TECH & RES

Traditional Chinese medicine effervescent tablet for treating cervical carcinoma and preparation method and application thereof

The invention discloses a traditional Chinese medicine effervescent tablet for treating cervical carcinoma. The traditional Chinese medicine effervescent tablet is prepared from glycyrrhiza inflata root standard extract, pomegranate bark standard extract, rhizoma galangae standard extract, galla turcica standard extract and an auxiliary material matrix. According to the preparation method, firstly, the standard extracts of various traditional Chinese medicine materials are obtained by adopting different methods, and then the standard extracts are mixed to prepare the effervescent tablet. According to the preparation method, by taking urgur traditional medicine and modern medical theories as guidance, on the basis of a medical formula taking pomegranate bark, galla turcica and the like as monarch drugs and used for sterilizing, inflammation diminishing, dampness eliminating and astringing, and cervicitis and cervical erosion resisting in the urgur traditional medicine, glycyrrhiza inflate roots and rhizoma galangae are added to optimize the formula composition to prepare the effervescent tablet, and thus, the effective composition component is increased, the effect range is broadened, and the pharmacological effect and the application value are improved. The effervescent tablet disclosed by the invention has good application value in interventional therapy of current high-incidence gynecological tumor-cervical carcinoma.
Owner:XINJIANG MEDICAL UNIV

Medical gynecological tumor clinical treatment operation auxiliary device

The invention belongs to the technical field of medical operation auxiliary equipment, and particularly discloses a medical gynecological tumor clinical treatment operation auxiliary device which comprises a first bottom plate, a second bottom plate, a bed plate, a lifting device, damping wheels, a rain shelter and a movable plate. The first bottom plate and the second bottom plate are mutually spliced, a bed plate is arranged above the first bottom plate and the second bottom plate, and a hinge is arranged in the middle of the bed plate; lifting devices are arranged between the bed board andthe first bottom board and between the bed board and the second bottom board. Symmetrical sliding grooves are formed in the bed board, symmetrical moving wheels are fixed to the bottom of the movableplate, and the moving wheels are connected with the sliding grooves in a sliding and clamping mode. A first barb plate is fixed at the bottom of the moving plate; symmetrical second barb plates are fixed to the positions, located on the two sides of the hinge, of the bed plate. Elastic clamping pieces are fixed to the corners of the two sides of the bed plate, a frame is fixed to the edge of the bottom of the rain shelter, supporting rods are fixed to the four corners of the frame, clamping rods are fixed to the bottom ends of the supporting rods, and the clamping rods are connected with the elastic clamping pieces in a clamped mode.
Owner:SHANGHAI UNIV OF MEDICINE & HEALTH SCI

After-loading transfer bed for gynecological tumor radiotherapy

A lifting device is arranged between a bed board and a bottom frame, the lifting device comprises a bearing plate, a supporting mechanism and a safety lock, the supporting mechanism comprises vertical frames, air springs and connecting rod assemblies which are symmetrically arranged, the two connecting rod assemblies are connected through carrier rollers, the carrier rollers make contact with the bottom face of the bearing plate, and the safety lock is arranged on the supporting plate. One end of each air spring is rotationally connected to the corresponding vertical frame, the other end of each air spring acts on the corresponding connecting rod assembly, the two vertical frames are fixed to the bottom frame, one end of the bearing plate is connected with the synchronous plate, the two sides of the synchronous plate are connected with the wing plates respectively, and the roller sets arranged on the synchronous plate and the wing plates can slide along the vertical frames; the safety locks are symmetrically arranged on the two sides of the bearing plate, each safety lock comprises a ratchet strip and a bidirectional pawl mechanism, the ratchet strips are fixed to the corresponding vertical frames, the bidirectional pawl mechanisms are rotationally arranged on the corresponding wing plates, brake cables used for controlling bidirectional pawls are connected to the brake handles, and the brake handles are connected to the control plate. The transfer bed is stable and comfortable in transfer and safe and reliable in locking.
Owner:AFFILIATED CANCER HOSPITAL OF SHANDONG FIRST MEDICAL UNIV SHANDONG CANCER INST (SHANDONG CANCER HOSPITAL)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products